We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

HRT · Special situations

HRT and uterine fibroids: what to know

Uterine fibroids typically shrink after menopause as estrogen falls. HRT can stimulate residual fibroids, but most women with fibroids can still use HRT safely with the right monitoring plan.

Written by the Kindr Health Editorial & Clinical TeamMedically reviewed by Kindr Health Clinical Team NPI 1609792902Published Last reviewed

Practical protocol

  • Baseline pelvic ultrasound
  • Transdermal estradiol, lowest effective dose
  • Continuous combined regimen preferred
  • Repeat ultrasound at 6–12 months if symptomatic

Frequently asked questions

Does HRT make fibroids grow?

It can — especially with higher-dose oral estrogen. Transdermal at the lowest effective dose is preferred.

Can I still use HRT with fibroids?

Usually yes, with baseline ultrasound and periodic follow-up if symptomatic.

Which route is best?

Transdermal estradiol + progesterone or Mirena IUD.

What symptoms warrant reassessment?

New heavy bleeding, pelvic pressure, rapid uterine enlargement.

Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.

Request your Longevity Consult →

Explore Kindr Health

HRT Hub →
Estrogen, progesterone, testosterone protocols
34 Symptoms →
The complete symptom index
Care Near Me →
Find menopause care in your city
Browse by State →
Licensed clinicians in all 50 states
Kindr Journal →
Evidence-based menopause reporting
Editorial Team →
Who reviews Kindr clinical content

Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service

Written and medically reviewed by the Kindr Health Clinical Team · Published 2026-06-19 · Last reviewed 2026-07-01. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.